Products Antibodies Polyclonal Antibodies [KO Validated] Anti-IRF9 Polyclonal Antibody for WB, ELISA - Q00978

No Image

Polyclonal Antibodies

[KO Validated] Anti-IRF9 Polyclonal Antibody for WB, ELISA - Q00978

Item Number : CM0021460

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human
Protein Weight
44kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name [KO Validated] IRF9 Rabbit pAb
Remarks/Alias p48; IRF-9; ISGF3; ISGF3G; F9
Species Human
Gene ID 10379
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 113-255 of human IRF9 (NP_006075.3)
Source Rabbit
Category Polyclonal Antibodies
Application WB, ELISA
Cross Reactivity Human
SWISS Q00978
Protein Weight 44kDa
Shipping Ice bag

Biological Background: IRF9 Function and Localization

  • IRF9 (Interferon regulatory factor 9), also known as ISGF3γ or p48, is a key transcription factor in the type I interferon (IFN-α/β) signaling pathway.
  • Upon type I IFN binding to cell surface receptors, kinases TYK2 and JAK1 are activated, leading to tyrosine phosphorylation of STAT1 and STAT2.
  • IRF9 associates with phosphorylated STAT1:STAT2 dimer to form the ISGF3 complex, which translocates to the nucleus.
  • In the nucleus, ISGF3 binds to the interferon-stimulated response element (ISRE) to drive transcription of interferon-stimulated genes (ISGs), inducing an antiviral state.
  • IRF9 belongs to the interferon regulatory factor family and is critical for innate antiviral immunity.
  • Subcellularly, IRF9 shuttles between the cytoplasm and nucleus; its nuclear accumulation is enhanced upon IFN signaling.
  • Post-translational modifications include phosphorylation and ubiquitin-like conjugation, which may regulate its activity and stability.

Experimental Guidance and Technical Tips

  • The antibody is identified as KO-validated by the supplier; use this feature to confirm specificity in your own experimental setup.
  • For Western blot, a band around 44 kDa is expected; include both positive (e.g., IFN-treated human cells) and negative controls.
  • In ELISA, optimize coating conditions and antibody concentrations for your specific assay format.
  • Being a polyclonal preparation, lot-to-lot consistency should be verified if used in quantitative or diagnostic applications.
  • The immunogen covers amino acids 113–255, so the antibody may recognize multiple IRF9 isoforms sharing this epitope; verify in your sample context.
  • When using out-of-species from the validated human cross-reactivity, perform preliminary testing to confirm reactivity.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio is your dedicated one-stop partner for IVD raw-material sourcing, from validated antibody pairs to bulk ancillary reagents. This anti-IRF9 polyclonal antibody supports research into interferon signaling and innate immunity, critical areas for diagnostic development. Trust our integrated supply chain to deliver consistent, high-quality materials for your projects, from concept to clinic.

View more faqs for this product

Product Datasheet

[KO Validated] Anti-IRF9 Polyclonal Antibody for WB, ELISA - Q00978


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!